Important Note: Redirection of Services to ChiCTR
We would like to inform you that the Clinical Trial Registry page will discontinue the function of updating trial information directly on this platform. However, you will still be able to view the existing registration details. For any updates to trial information, you can use the China Clinical Trial Registry (ChiCTR) directly at https://www.chictr.org.cn. This change will be fully implemented by 2024-Aug-05. Thank you for your attention.
CUHK_CCT00272
A randomized controlled trial of intravitreal bevacizumab monotherapy versus triple therapy with half fluence verteporfin photodynamic therapy and intravitreal bevacizumab and triamcinolone acetonide for the treatment of neovascular age-related macular degeneration
2010-11-30
|
|
|
|
|
|---|---|---|---|
| 2014-05-07 | Complete | Registry User | Detail |
| 2013-04-30 | Suspended | Registry User | Detail |
| 2012-07-13 | Complete | Registry User | Detail |
| 2011-06-20 | Complete | Registry User | Detail |
| 2011-03-21 | Recruiting | Registry User | Detail |
| 2011-02-08 | Recruiting | Administrator | Detail |
| 2010-11-30 | Recruiting | Registry User | Detail |